Glenmark Pharmaceuticals Ltd., a global pharmaceuticals company, has launched the next phase of its ‘India First Heart First’ campaign. Building on the success and momentum of the initial phase, this nationwide initiative marks a significant step forward in addressing heart health challenges across India. The campaign underscores Glenmark’s commitment to addressing the critical health challenges posed by cardiovascular diseases (CVD).
The campaign began with a World Heart Day event on September 29, 2023, featuring artist Sudarsan Pattnaik’s sand sculpture of a human heart at Puri beach. On World Hypertension Day 2024, the campaign marked another milestone. Glenmark collaborated with President’s Award winner Prithviraj Kumawat to create a monumental human heart sculpture from Rose quartz, associated with the heart chakra and promoting emotional balance.
The sculpture, standing 8 feet tall and weighing 3.5 tons, was unveiled on May 17, 2024, attended by cardiologists from Delhi and Jaipur. Mr. Alok Malik, President and Business Head – India Formulations, Glenmark Pharmaceuticals Ltd. said, “Through the ‘India First Heart First’ campaign, we are not just raising awareness; we are building a movement.” 35,000 doctors from across India sent in their pledges to support cardiovascular disease awareness. Their signed pledge cards were displayed at the base of the sculpture, reinforcing the collective commitment to this cause.